RobertaDeBiasiMDMS

Summary

• Dr. DeBiasi is Chief of the Division of Pediatric Infectious Diseases and leads the institutional emerging infections response team at Children's National. She serves as attending physician for immunocompetent and immunocompromised children hospitalized with severe infections. She is tenured Professor of Pediatrics, Microbiology, Immunology and Tropical Medicine at The George Washington University School of Medicine and Health Sciences. Dr. DeBiasi 's research expertise encompasses both basic and clinical/translational research focused on mechanisms, pathogenesis, and development of new therapeutic targets for severe and emerging viral infections, for which she has funding sources including the Infectious Diseases Society of America and the NIH National Institute of Allergy and Infectious Disease. She is currently Principal Investigator at Children's Research Institute for clinical/translational research and trials, focusing on pathogenesis and improved treatments for SARS CoV-2, Zika, viral myocarditis, encephalitis, influenza, neonatal herpes simplex virus, congenital cytomegalovirus, as well as Lyme Disease. She is an active investigator in the NIAID Collaborative Antiviral Study Group and Chair of the Institutional Biosafety Committee. Dr. DeBiasi has authored >100 original peer-reviewed publictions including original research, review articles, and book chapters. She served as the former fellowship training program director in the Division of Pediatric Infectious Diseases, and greatly enjoys teaching and mentoring graduate and medical students, residents, and fellows in the classroom, the hospital wards, and in clinical research projects. She is also actively engaged in continuing medical education for community physicians and medical education outreach to the community.